The downward trend continues in the cryptocurrency market today. Bitcoin (BTC) $96,907.4 It fell below 95 thousand dollars, making investors nervous. Total market value decreased by 2 percent to $3.27 trillion. Daily transaction volume decreased by 15 percent to 138 billion dollars. The Fear and Greed Index also fell from 59 to 54, reflecting the instability in the market.
Losses in Altcoins Increase
The decline in Bitcoin was also reflected in other major altcoins. Ethereum (ETH) $3,381.7 2 percent, Ripple
$2.3 (XRP) lost 4 percent of its value. David Schwartz, Ripple Labs’ new stablecoin RLUSDHe drew attention to XRP by explaining its benefits. Schwartz said that this stablecoin offers significant opportunities for users and developers on the XRP Ledger. solana (SOL) was traded at $182, while its market value remained stable at $87 billion.
![](/wp-content/uploads/2024/12/The-Cryptocurrency-Market-Continues-to-Decline-Latest-Situation-in-Bitcoin.jpeg)
One of the popular altcoins of recent days hyperliquid (HYPE) surprised investors by falling 19 percent. HYPE had been among the top gainers over the previous two days. Memecoin‘s followed a similar trend, falling between 2 percent and 4 percent.
Trump’s Digital Asset Move
With all this, the President of the United States Donald Trumptook a new step towards the digital asset sector. To the Presidential Digital Asset Advisory Committee Bo HinesAppointed as Executive Director. The committee aims to support the development and innovation of digital assets. committee chairman David Sacksstated that this step could be a turning point in the industry.
Despite the recent negative developments, Bitcoin’s 2 percent increase in the short term gave hope to investors. However, the market-wide pressure continues. Experts warn that investors should be careful.
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that crypto currencies carry high volatility and therefore risk, and should carry out their transactions in line with their own research.